Table 1.
Variable | N (%) |
---|---|
Injection drug using people living with HIV/AIDS | 1727 |
Age, y | |
<30 | 283 (16.4) |
30–39 | 666 (38.6) |
40–49 | 573 (33.2) |
50+ | 205 (11.9) |
Female gender | 575 (33.3) |
Aboriginal | 455 (26.3) |
Health authority of residence | |
Interior | 109 (6.3) |
Fraser | 391 (22.6) |
Vancouver Coastal | 900 (52.1) |
Vancouver Island | 244 (14.1) |
Northern | 83 (4.8) |
On OST | 612 (35.4) |
CD4, cells/mm3 | |
<200 | 792 (46) |
200–499 | 719 (41.8) |
≥500 | 210 (12.2) |
Prior OST episodes | |
0 | 969 (56.1) |
1 | 410 (23.7) |
≥2 | 348 (20.2) |
Charlson comorbidity index (>0) | 575 (33.3) |
AIDS status | 231 (13.4) |
Calendar year | |
1996–1999 | 626 (36.2) |
2000–2003 | 378 (21.9) |
2004–2010 | 723 (41.9) |
Possible endpoints: censored | 1234 (71.5) |
Drug-related death | 92 (5.3) |
Human immunodeficiency virus–related death | 275 (15.9) |
Other-related death | 126 (7.3) |
Abbreviations: HIV, human immunodeficiency virus; OST, opioid substitution treatment.